# Translate Bio, Inc.

Translate Bio, Inc. is a company headquartered in Lexington, MA, United States.

## Company overview

- **Legal name:** Translate Bio, Inc.
- **Former names in filing history:** RaNA Therapeutics, Inc. (2017-01-05 to 2017-01-05)
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Lexington, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001693415

## About

Translate Bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001693415, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2021-03-01, it reported annual revenue of USD 138,811,000; net income of USD -53,787,000; total assets of USD 889,936,000 for the fiscal period ended 2020-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2020 (period ended 2020-12-31)

- **Revenue:** $138.8M (USD 138,811,000)
- **Net income:** -$53.8M (USD -53,787,000)
- **Total assets:** $889.9M (USD 889,936,000)
- **Cash and equivalents:** $342.0M (USD 342,027,000)
- **Operating cash flow:** $236.3M (USD 236,316,000)

### FY2019 (period ended 2019-12-31)

- **Revenue:** $7.8M (USD 7,804,000)
- **Net income:** -$113.3M (USD -113,293,000)
- **Total assets:** $336.2M (USD 336,201,000)
- **Cash and equivalents:** $84.6M (USD 84,580,000)
- **Operating cash flow:** -$82.2M (USD -82,162,000)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $1.4M (USD 1,420,000)
- **Net income:** -$97.4M (USD -97,395,000)
- **Total assets:** $287.7M (USD 287,651,000)
- **Cash and equivalents:** $55.2M (USD 55,199,000)
- **Operating cash flow:** -$22.1M (USD -22,133,000)

## Recent SEC filings

- Form 8-K — filed 2021-09-14 — period 2021-09-14 — 8-K
- Form SC 13D — filed 2021-08-16 — SCHEDULE 13D
- Form SC 13D — filed 2021-08-12 — SC 13D
- Form 10-Q — filed 2021-08-05 — period 2021-06-30 — 10-Q
- Form 8-K — filed 2021-08-03 — period 2021-08-02 — 8-K
- Form 8-K — filed 2021-06-16 — period 2021-06-16 — 8-K
- Form 10-Q — filed 2021-05-06 — period 2021-03-31 — 10-Q
- Form 8-K — filed 2021-04-20 — period 2021-04-19 — 8-K
- Form DEF 14A — filed 2021-04-19 — period 2021-06-16 — DEF 14A
- Form 8-K — filed 2021-03-23 — period 2021-03-18 — 8-K
- Form 10-K — filed 2021-03-01 — period 2020-12-31 — 10-K
- Form 8-K — filed 2021-02-25 — period 2021-02-25 — 8-K

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/translate-bio-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology